Medication Guide for Roxithromycin

Pharmacological Class

Roxithromycin belongs to the class of medications known as macrolide antibiotics. It functions by inhibiting bacterial protein synthesis, thereby preventing bacterial growth and replication.

Mechanism of Action

Roxithromycin binds to the 50S ribosomal subunit of susceptible bacteria, inhibiting the translocation of peptides. This action disrupts the elongation phase of protein synthesis, leading to bacteriostasis.

Indications for Use

Roxithromycin is indicated for the treatment of various bacterial infections, including respiratory tract infections, urinary tract infections, and skin and soft tissue infections. It is also effective against infections caused by atypical pathogens like Mycoplasma pneumoniae and Chlamydia trachomatis.

Administration Route

Roxithromycin is administered orally. The tablets should be swallowed whole with water. It is recommended to take the medication on an empty stomach for optimal absorption, either 30 minutes before or 2 hours after a meal.

Dosage Recommendations

The usual dosage for adults is 150 mg twice daily or 300 mg once daily. The duration of treatment typically ranges from 5 to 10 days, depending on the severity and type of infection. Dose adjustments may be necessary for patients with impaired liver function.

Storage Conditions

Store Roxithromycin at room temperature, between 20°C to 25°C (68°F to 77°F). Keep the medication in a tightly closed container, away from direct sunlight, heat, and moisture. Keep out of reach of children.

Contraindications

Roxithromycin is contraindicated in patients with known hypersensitivity to macrolide antibiotics. It should not be used in individuals with severe hepatic impairment or in those taking concomitant ergot alkaloids due to the risk of ergotism.

Potential Drug Interactions

Roxithromycin may interact with other medications, including warfarin, theophylline, digoxin, and certain statins, potentially increasing their serum concentrations. Co-administration with strong CYP3A4 inhibitors or inducers may alter Roxithromycin metabolism.

Adverse Effects

Common adverse effects include gastrointestinal disturbances such as nausea, vomiting, abdominal pain, and diarrhea. Less commonly, dizziness, headache, and hepatotoxicity may occur. In rare cases, severe allergic reactions and QT prolongation have been reported.

Monitoring Parameters

Monitor liver function tests periodically in patients receiving prolonged therapy or those with pre-existing liver disease. Regularly assess symptom resolution and bacterial eradication to ensure treatment efficacy. Monitor for signs of adverse effects, especially in high-risk populations.

Patient Counseling Points

Advise patients to complete the full course of therapy, even if symptoms improve before the medication is finished. Stress the importance of taking the medication at the same time each day to maintain consistent blood levels. Inform patients to avoid consuming grapefruit juice during treatment as it may interfere with the drug’s efficacy.

Special Populations Considerations

Pregnant and breastfeeding women should use Roxithromycin only if the potential benefits justify the potential risks. Dose adjustment may be needed in elderly patients and those with significant renal or hepatic impairment. Pediatric use should be based on a careful assessment of the risk-benefit ratio.

Mechanism-Specific Resistance

Bacterial resistance to Roxithromycin can occur through various mechanisms, including alteration of the ribosomal target site, efflux pumps, and enzymatic degradation. Cross-resistance with other macrolides may occur, necessitating susceptibility testing for guiding therapy.